|
PMID
|
Match String
|
Actual String
|
Score
|
Flanking text
|
Edited by
|
Edit
|
| 17241118 | CB2 | CB2 | 0.9 | The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model | |  |
| 17241118 | CB2 | CB2 | 0.9 | cannabinoid receptor 1 (CB1) CB1 and cannabinoid receptor 2 (CB2), CB2 and delay the progression of neuroinflammatory diseases | |  |
| 17241118 | CB2 | CB2 | 0.9 | Additionally CB2 receptors which normally exist primarily in the periphery are dramatically | |  |
| 17241118 | CB2 | CB2 | 0.9 | We demonstrate that mRNA receptor binding and function of CB2 but not CB1 receptors are dramatically and selectively up-regulated in | |  |
| 17241118 | CB2 | CB2 | 0.9 | More importantly daily injections of the selective CB2 agonist AM-1241 initiated at symptom onset increase the survival interval | |  |
| 17241118 | CB2 | CB2 | 0.9 | Therefore CB2 agonists may slow motor neuron degeneration and preserve motor function | |  |
| 17241118 | cannabinoid receptor 2 | cannabinoid receptor 2 | 1.0 | cannabinoids produce anti inflammatory actions via cannabinoid receptor 1 cb1 and cannabinoid receptor 2 cb2 and delay the progression of neuroinflammatory diseases. | |  |